Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-level Recall Of One Lot Of Propranolol Hydrochloride Extended-release Capsules, Usp, 60 Mg, Due To Potential Metal Contamination

Recall Summary Breckenridge Pharmaceutical is recalling one lot of Propranolol Hydrochloride Extended-Release Capsules (60 mg) nationwide because the medication may contain metal particles. This blood pressure and heart medication was manufactured by Adare Pharma Solutions and affects consumers who have this specific lot.

Recalling firm
Breckenridge Pharmaceutical, Inc. Issues Voluntary Nationwide Consumer-Level
Product
One Lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg,
Reason
November 16, 2026— Breckenridge Pharmaceutical, Inc. (Breckenridge) is voluntarily recalling to the consumer level one lot of Propranolol Hydrochloride Extended-Release Capsules, USP, 60 mg, manufactured by Adare Pharma Solutions, due to potential metal contamination.
Category
drug recall
Country
United States
Agency
FDA-MEDWATCH-RSS
Recall date
2026-11-20
Status
Ongoing

Official recall notice from FDA-MEDWATCH-RSS

Recall details on Nibble Recalls: https://trynibble.app/recalls/9884d522-e084-485b-9fac-1617dc458d20